Psoriasis is a chronic and debilitating inflammatory disease associated with serious
comorbidities. Psoriasis can have a significant impact on a patient's quality of life and is …

Psoriasis is a chronic immune-inflammatory-mediated disease that can predispose patients
to other inflammatory conditions. For example, individuals with psoriasis are at increased …

Psoriasis is an inflammatory, immune‐mediated cutaneous disorder that has recently been
recognized as systemic disease that is associated with multiple comorbidities such as …

Psoriasis is a common chronic inflammatory disease that is associated with serious
comorbidities, including psoriatic arthritis, reduced quality of life, depression, malignancy …

Psoriasis is a common Th-1 and Th-17-mediated chronic inflammatory disease that has
been associated with metabolic syndrome, a constellation of cardiovascular risk factors …

Psoriasis is a multi-systemic chronic inflammatory skin disease targeting 2% to 3% of the
general population. It is a prototype of immune dysregulation mediated by TH1 …

Once considered to be solely a cutaneous disease, there is now robust evidence that
psoriasis is associated with systemic inflammation and a significantly increased risk of …

Psoriasis is a chronic inflammatory, immune-mediated skin disease, which affects 2%-3% of
the population worldwide. Chronic plaque psoriasis is frequently associated with metabolic …

Psoriasis is a chronic inflammatory disorder that affects approximately 2% of the general
population. Numerous studies have evaluated the increased prevalence of comorbid …

Psoriasis (PsO) and psoriatic arthritis (PsA) are chronic T cell‐mediated inflammatory
diseases that manifest not only in the skin and joints but also in the form of cardiometabolic …